Navigation Links
Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories
Date:7/11/2013

MARKHAM, Ontario, July 11, 2013 /PRNewswire/ -- This morning Ensil Canada announced the exciting news that its scientific team of researchers and engineers have made a major breakthrough in the development of a revolutionary medical product that has the potential to help patients who suffer from mobility issues.

Ensil Canada has completed successful test results that show a proprietary communication device can be used to communicate with the brain and bypass the spine. This breakthrough meets the targets set by Ensil to have a prototype of a device by the end of 2013 for more comprehensive testing.

"We are very proud and confident that we have developed a product at our Ontario, Canada facilities that could help tens of thousands of people who suffer from mobility issues," said Farsad Kiani, CEO of Ensil Canada. "This is a phenomenal first step. It is our hope that we can bring this product to market, so that people can continue enjoying their day to day activities such as jogging, swimming and walking."

Today's announcement is one of the many areas of research by Ensil Canada to improve the lives of people across the world. Over the past three decades, Ensil Canada has made many positive breakthroughs and worked in the community to improve people's health and wellbeing. Recent work has included major advancements in the quality of the life of those whose their life has been affected by Stroke, Multiple Scoliosis, Spinal Cord injury or paralysis.

Ensil Canada focuses on enhancing mission critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's research and development divisions' mission is to develop new technologies or improve existing technologies through its own in-house research activities and resources.

Ensil Canada, a member of Ensil group of companies (www.ensil.ca), focuses on enhancing mission critical technologies in the areas of aerospace, defence, telecommunication and medical diagnostic equipment.

Ensil's R&D divisions' mission is to develop new technologies or improve existing technologies through in-house research activities.

For further information please contact us at: info @ensil.com or visit us at www.ensil.ca.

This press release was issued through 24-7PressRelease.com.  For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Ensil Canada Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
2. Canada-based Radimetrics Announces Expansion to Scotland
3. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
6. VirtualScopics Receives Issuance of Influential Patent in Canada
7. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
8. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
9. Sensus Healthcare Announces Health Canada Approval
10. New Treatment For Obstructive Sleep Apnea Now Available In Canada
11. Integrated Marketing Company Expands Into Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... SUNNYVALE, Calif. , Jan. 19, 2017 ... that its CyberKnife® and TomoTherapy® Systems continue to set ... systems received the highest composite overall user satisfaction rating ... to the Q4 2016 MD Buyline Market Intelligence Briefing™. ... achieved the highest composite ratings among industry peers for ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
(Date:1/19/2017)... SAN FRANCISCO , January 19, 2017 The global  ... a new report by Grand View Research, Inc. The heightening prevalence of cardiac ... governing the growth of Pacemaker globally. In addition, technological enhancements in these devices ... Reading ... Grand View Research Logo ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages ... Real Impact contest from Impact Teen Drivers and California Casualty. Entries from students ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer messages ...
(Date:1/19/2017)... ... 2017 , ... Bill Howe Plumbing, Heating & Air in San Diego announces ... Healthy is Your Heart Drawing Contest The drawing contest asks children to draw ... Heating & Air receives over 600 entries. The culmination of the joint effort will ...
(Date:1/19/2017)... ... ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today that it ... years SFI has been recognized as the world’s leader in Intelligent Sales Outsourcing Solutions. ... market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, Ariello, Inc. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Breast Surgery Symposium, a conference where hundreds of surgeons from over fifteen different ... Covering topics from cosmetic breast augmentation to breast reconstruction for breast ...
(Date:1/18/2017)... Austin, TX (PRWEB) , ... January 18, 2017 , ... ... million people opened a global discussion about the benefits of fidgeting to relieve stress ... Lyon and Jym Daniel. Their Think Ink Pen had just completed a successful ...
Breaking Medicine News(10 mins):